Bonnet F - Search Results

1

Understanding and overcoming metformin gastrointestinal intolerance.

Bonnet F, Scheen A. Bonnet F, et al. Diabetes Obes Metab. 2017 Apr;19(4):473-481. doi: 10.1111/dom.12854. Epub 2017 Feb 22. Diabetes Obes Metab. 2017. PMID: 27987248 Review.

2

Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.

Wessman M, Forsblom C, Kaunisto MA, Söderlund J, Ilonen J, Sallinen R, Hiekkalinna T, Parkkonen M, Maxwell AP, Tarnow L, Parving HH, Hadjadj S, Marre M, Peltonen L, Groop PH; FinnDiane Study Group. Wessman M, et al. PLoS One. 2011;6(9):e24053. doi: 10.1371/journal.pone.0024053. Epub 2011 Sep 1. PLoS One. 2011. PMID: 21909410 Free PMC article.

3

Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study.

Gautier A, Roussel R, Lange C, Piguel X, Cauchi S, Vol S, Froguel P, Balkau B, Bonnet F. Gautier A, et al. Among authors: bonnet f. Diabetes. 2011 Oct;60(10):2654-63. doi: 10.2337/db10-1442. Epub 2011 Sep 12. Diabetes. 2011. PMID: 21911746 Free PMC article.

4

Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?

Bonnet F, Scheen AJ. Bonnet F, et al. Diabetes Metab. 2014 Dec;40(6 Suppl 1):S1-3. doi: 10.1016/S1262-3636(14)72688-6. Diabetes Metab. 2014. PMID: 25554065 Free article. No abstract available.

5

Functional gastrointestinal disorders and incidence of type 2 diabetes: Evidence from the E3N-EPIC cohort study.

Fagherazzi G, Gusto G, Balkau B, Boutron-Ruault MC, Clavel-Chapelon F, Bonnet F. Fagherazzi G, et al. Among authors: bonnet f. Diabetes Metab. 2016 Jun;42(3):178-83. doi: 10.1016/j.diabet.2015.11.006. Epub 2015 Dec 28. Diabetes Metab. 2016. PMID: 26738848 Free article.

6

GLP-1 receptor agonist confer target organ protection in type 2 diabetes.

Bonnet F. Bonnet F. Diabetes Metab. 2017 Apr;43 Suppl 1:2S1-2S2. doi: 10.1016/S1262-3636(17)30066-6. Diabetes Metab. 2017. PMID: 28431665 No abstract available.

7

Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program.

Ji L, Bonnet F, Charbonnel B, Gomes MB, Kosiborod M, Khunti K, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Watada H, Fenici P, Hammar N, Hashigami K, Macaraeg G, Surmont F, Medina J. Ji L, et al. Among authors: bonnet f. J Diabetes Complications. 2017 Jul;31(7):1188-1196. doi: 10.1016/j.jdiacomp.2017.03.011. Epub 2017 Apr 5. J Diabetes Complications. 2017. PMID: 28499961 Free article.

8

Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes.

Bonnet F, Scheen AJ. Bonnet F, et al. Diabetes Metab. 2017 Sep;43(4):299-313. doi: 10.1016/j.diabet.2017.04.004. Epub 2017 May 15. Diabetes Metab. 2017. PMID: 28522196 Review.

9

Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease.

Bonnet F, Scheen AJ. Bonnet F, et al. Diabetes Metab. 2018 Dec;44(6):457-464. doi: 10.1016/j.diabet.2018.09.005. Epub 2018 Sep 26. Diabetes Metab. 2018. PMID: 30266577 Review.

10

Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes.

Mantovani A, Altomari A, Fassio A, Gatti D, Bonnet F, Targher G. Mantovani A, et al. Among authors: bonnet f. Diabetes Metab. 2020 Oct;46(5):409-411. doi: 10.1016/j.diabet.2019.02.005. Epub 2019 Mar 4. Diabetes Metab. 2020. PMID: 30844448 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,170 results

Search Page